Company: GNMSF
Filing Date: 2025-08-07
Form Type: 6-K
Source: 0001434265-25-000063
Chunk: 47

Company: GENMAB A/S
Filing Date: 2025-08-07
Form: 6-K
Chunk 47
---
 | $                         |  -14 |     | $    |  -7 |
| Loss on marketable securities         |     |                             |  -5 |     |      | -26 |     |                           |  -12 |     |      | -49 |
| Foreign exchange rate loss            |     |                             | -77 |     |      | -17 |     |                           | -108 |     |      | -24 |
| Total financial expenses              |     | $                           | -91 |     | $    | -46 |     | $                         | -134 |     | $    | -80 |
| Net financial items                   |     | $                           |  63 |     | $    |  71 |     | $                         |  119 |     | $    | 204 |

Note 7 - Share-Based Payments

Restricted Stock Unit Program

Genmab has established an RSU program (equity-settled share-based payment transactions) as an incentive for Genmab’s employees, members of the Executive Management, and members of the Board of Directors. RSUs granted to Executive Management are performance-based (PSUs).

|                                                   |     | Six Months Ended |          |         |     |      |          |         |
|                                                   |     |         June 30, |          |         |     |      |          |         |
|                                                   |     |             2025 |          |         |     | 2024 |          |         |
| RSUs granted                                      |     |                  |          | 636,825 |     |      |          | 452,485 |
| Weighted average fair value per RSU granted (DKK) |     |                  | 1,601.95 |         |     |      | 2,010.05 |         |
| RSUs vested                                       |     |                  |          | 180,822 |     |      |          | 130,579 |

Refer to Note 4.6 in the Annual Report for details on the RSU program.

Warrant Program

Genmab has established a warrant program (equity-settled share-based payment transactions) as an incentive for all Genmab employees.

| Genmab A/S            
 Carl Jacobsens Vej 30 
 2500 Valby, Denmark   |     | Tel: +45 7020 2728 
 www.genmab.com     |     | Company Announcement no. 40 
 Page 39